Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-04 Sale |
2021-01-05 4:47 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
8,334 | $32.88 | $274,022 | 298,923 (Direct) |
View |
| 2020-11-11 Sale |
2020-11-13 5:05 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
15,000 | $24.05 | $360,750 | 201,264 (Direct) |
View |
| 2020-09-02 Sale |
2020-09-04 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
10,000 | $20 | $200,000 | 216,264 (Direct) |
View |
| 2020-08-13 Sale |
2020-08-14 5:15 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
10,000 | $18 | $180,000 | 246,230 (Direct) |
View |
| 2020-08-07 Purchase |
2020-08-11 11:44 am |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
15,000 | $17.49 | $262,350 | 15,000 (Direct) |
View |
| 2020-08-06 Sale |
2020-08-07 5:27 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
10,000 | $17.01 | $170,100 | 256,230 (Direct) |
View |
| 2020-07-16 Sale |
2020-07-17 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
6,667 | $15 | $100,005 | 246,230 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-04 Exercise |
2021-01-05 4:47 pm |
2017-03-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
4,566 | $2.46 | 298,923 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-05 4:47 pm |
2020-03-31 2025-03-11 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
4,000 | $7.51 | 298,923 (Direct) |
View |
| 2020-09-30 Option Award |
2021-01-05 4:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
1,985 | $0 | 16,985 (Direct) |
View |
| 2020-09-30 Option Award |
2021-01-05 4:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
1,985 | $0 | 31,944 (Direct) |
View |
| 2020-09-30 Option Award |
2021-01-05 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
1,985 | $0 | 21,389 (Direct) |
View |
| 2020-09-30 Option Award |
2021-01-05 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
1,985 | $0 | 63,882 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 5:05 pm |
2017-03-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
15,000 | $2.46 | 201,264 (Direct) |
View |
| 2020-09-02 Exercise |
2020-09-04 4:45 pm |
2017-03-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
10,000 | $2.46 | 216,264 (Direct) |
View |
| 2020-08-14 Exercise |
2020-08-14 5:15 pm |
2017-03-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
10,000 | $2.46 | 246,230 (Direct) |
View |
Ownership |
2020-08-11 09:22 am |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
0 | $0 | 0 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-07 5:27 pm |
2017-03-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
10,000 | $2.46 | 256,230 (Direct) |
View |
| 2020-07-17 Exercise |
2020-07-17 4:45 pm |
2017-03-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
8,000 | $2.46 | 246,230 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:36 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
1,937 | $0 | 29,959 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:35 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
1,937 | $0 | 19,404 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:33 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
1,937 | $0 | 29,729 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:33 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
1,937 | $0 | 61,897 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 4:32 pm |
2020-06-30 2020-12-31 |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
21,187 | $0 | 272,091 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 08:45 am |
2017-02-22 2021-02-21 |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
45,261 | $3.21 | 603,267 (Direct) |
View |
| 2020-06-03 Exercise |
2020-06-04 4:15 pm |
2020-06-03 2020-06-24 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
23,302 | $0 | 252,897 (Direct) |
View |
| 2020-06-03 Exercise |
2020-06-04 4:15 pm |
N/A N/A |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
17,421 | $3.15 | 252,897 (Direct) |
View |